Skip to content
healthcare.dev

Memantine Hydrochloride

NDC 69680-163, memantine hydrochloride, capsule, extended release, from Vitruvias Therapeutics, Inc..

Product NDC
69680-163
Status
Listed
Labeler
Vitruvias Therapeutics, Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213985
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69680-163 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MEMANTINE HYDROCHLORIDE21 mg/1

Pharmacologic classes

N-methyl-D-aspartate Receptor Antagonist [EPC]; NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
69680-163-306968001633030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69680-163-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0c7fd6ab-2ce5-4110-b6e6-9103c8da0765
  • NADAC price for package 69680016330

    GET /v1/drugs/nadac/69680016330

Use it

Look up 69680-163 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69680-163 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69680-163. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.